• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

A statement from Professor Melanie Davies, Director of the BRC

Apr 7, 2020

Dear All,

“It would be an understatement to say that many of us are currently facing the greatest challenges of our professional and personal lives.

“I want to thank you all –  researchers, support staff, patients and volunteers – at the NIHR Leicester BRC, for going above and beyond to support the NHS and the local, national and international research response to COVID-19. The UK government has made it clear that swift, high quality research is needed now more than ever to take the fight to the novel coronavirus in order to save lives. As an NIHR biomedical research centre with a respiratory theme, this is what we are here for: rapid translational medicine from bench to bedside.

“We are all adapting to changes in day-to-day life, such as remote working and the use of video conferencing for consultations – changes which may become the ‘new normal’ for the NHS. Across all sites and themes we face unique challenges in response to the COVID-19 crisis and I am deeply moved by the remarkable resiliency and adaptability you have shown to provide the best research and patient care, even as circumstances quickly change.

“Many studies have had to be paused for the foreseeable future. While necessary for continued safety, it has been difficult and disappointing for those involved in the studies. I commend how staff have accomplished this while also continuing to support and inform patients. These changes have also allowed the BRC to focus efforts on the key research tasks ahead.

“Studies related to new COVID-19 research are rapidly being set up thanks to the tireless work by many of our colleagues, and many of you have moved to the respiratory team to support them in their efforts. Working with frontline clinicians at Leicester’s Hospitals, we are focused on nationally prioritised research, as set out in the NIHR Prioritisation Process and have already recruited to the RECOVERY and ISARIC trials. More studies, including clinical trials using novel therapies, will be coming on board in the next few weeks and months. These trials sit largely within the NIHR Respiratory Translational Research Collaboration, of which our centre plays a lead role.

“We are also part of the BREATHE Hub, collecting national datasets on respiratory illness. This will be mobilised to conduct detailed analyses of data on COVID-19, as collected by our NIHR colleagues at the Guys and St Thomas BRC and Kings College London. More epidemiological studies will be introduced in the next few months.

“Also many of our BRC staff are working with clinical colleagues in the NHS frontline to come up with innovative ways of supporting our patients to prevent hospital admissions.  I’m really proud of all the team who are working so hard and so flexibly under extremely tough conditions to do our collective best to keep our patients safe and to drive research forward to come up with effective treatment for this horrible disease.

“We will keep you updated as the situation continues to change, but once again thank you to each and every one of you.

“Stay safe and look out for each other.”

Professor Melanie Davies

NIHR Leicester BRC Director

Category: Press Releases, UncategorizedTag: News, statement

Sidebar

Recent News

Leicester health specialists receive NIHR prizes for excelling in their fields

Respiratory researcher awarded Asthma + Lung UK Junior Fellowship

Weight-loss drug users turn to social media over doctors for advice

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}